| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.98e-07 | 37 | 28 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.80e-05 | 441 | 28 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.84e-05 | 127 | 28 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | helicase activity | 6.66e-05 | 158 | 28 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.74e-04 | 614 | 28 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.63e-04 | 262 | 28 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 6.07e-04 | 775 | 28 | 6 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 9.20e-04 | 839 | 28 | 6 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 9.26e-04 | 840 | 28 | 6 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 9.26e-04 | 840 | 28 | 6 | GO:0016818 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.93e-03 | 206 | 28 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone binding | 5.92e-03 | 265 | 28 | 3 | GO:0042393 | |
| GeneOntologyMolecularFunction | methylated histone binding | 6.44e-03 | 86 | 28 | 2 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 6.74e-03 | 88 | 28 | 2 | GO:0140034 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 9.93e-03 | 320 | 28 | 3 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.04e-02 | 326 | 28 | 3 | GO:0001217 | |
| GeneOntologyCellularComponent | nuclear body | 1.86e-04 | 903 | 29 | 7 | GO:0016604 | |
| GeneOntologyCellularComponent | nuclear speck | 2.87e-04 | 431 | 29 | 5 | GO:0016607 | |
| Domain | Chromo_domain | 4.87e-08 | 24 | 29 | 4 | IPR023780 | |
| Domain | BRK | 6.71e-08 | 6 | 29 | 3 | SM00592 | |
| Domain | BRK_domain | 6.71e-08 | 6 | 29 | 3 | IPR006576 | |
| Domain | BRK | 6.71e-08 | 6 | 29 | 3 | PF07533 | |
| Domain | Chromo | 6.84e-08 | 26 | 29 | 4 | PF00385 | |
| Domain | CHROMO_2 | 9.35e-08 | 28 | 29 | 4 | PS50013 | |
| Domain | CHROMO_1 | 9.35e-08 | 28 | 29 | 4 | PS00598 | |
| Domain | SNF2_N | 1.64e-07 | 32 | 29 | 4 | PF00176 | |
| Domain | SNF2_N | 1.64e-07 | 32 | 29 | 4 | IPR000330 | |
| Domain | Chromodomain-like | 1.64e-07 | 32 | 29 | 4 | IPR016197 | |
| Domain | CHROMO | 1.86e-07 | 33 | 29 | 4 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.86e-07 | 33 | 29 | 4 | IPR000953 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.13e-05 | 35 | 29 | 3 | IPR002464 | |
| Domain | Helicase_C | 2.17e-05 | 107 | 29 | 4 | PF00271 | |
| Domain | HELICc | 2.17e-05 | 107 | 29 | 4 | SM00490 | |
| Domain | Helicase_C | 2.25e-05 | 108 | 29 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 2.33e-05 | 109 | 29 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.33e-05 | 109 | 29 | 4 | PS51192 | |
| Domain | DEXDc | 2.33e-05 | 109 | 29 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.41e-05 | 110 | 29 | 4 | IPR014001 | |
| Domain | DEAH_ATP_HELICASE | 2.74e-05 | 38 | 29 | 3 | PS00690 | |
| Domain | RRM_dom_euk | 5.77e-04 | 23 | 29 | 2 | IPR003954 | |
| Domain | RRM_1 | 5.77e-04 | 23 | 29 | 2 | SM00361 | |
| Domain | - | 8.60e-04 | 746 | 29 | 6 | 3.40.50.300 | |
| Domain | ZnF_U1 | 9.21e-04 | 29 | 29 | 2 | SM00451 | |
| Domain | Znf_U1 | 9.21e-04 | 29 | 29 | 2 | IPR003604 | |
| Domain | P-loop_NTPase | 1.67e-03 | 848 | 29 | 6 | IPR027417 | |
| Domain | RRM_1 | 4.02e-03 | 208 | 29 | 3 | PF00076 | |
| Domain | RRM_dom | 5.13e-03 | 227 | 29 | 3 | IPR000504 | |
| Domain | RRM | 5.32e-03 | 230 | 29 | 3 | PS50102 | |
| Domain | - | 6.26e-03 | 244 | 29 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 7.30e-03 | 258 | 29 | 3 | IPR012677 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.59e-06 | 430 | 30 | 6 | 35044719 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 28533432 | ||
| Pubmed | 9.85e-06 | 591 | 30 | 6 | 15231748 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.16e-05 | 608 | 30 | 6 | 36089195 | |
| Pubmed | 1.99e-05 | 1014 | 30 | 7 | 32416067 | ||
| Pubmed | 2.08e-05 | 1429 | 30 | 8 | 35140242 | ||
| Pubmed | 3.22e-05 | 10 | 30 | 2 | 25055868 | ||
| Pubmed | 4.10e-05 | 225 | 30 | 4 | 12168954 | ||
| Pubmed | 4.51e-05 | 1153 | 30 | 7 | 29845934 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 4.56e-05 | 1155 | 30 | 7 | 20360068 | |
| Pubmed | 5.57e-05 | 486 | 30 | 5 | 20936779 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.14e-04 | 109 | 30 | 3 | 33554859 | |
| Pubmed | 1.34e-04 | 115 | 30 | 3 | 17332742 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.42e-04 | 954 | 30 | 6 | 36373674 | |
| Pubmed | TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction. | 1.50e-04 | 21 | 30 | 2 | 20194497 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.56e-04 | 605 | 30 | 5 | 28977666 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.08e-04 | 1024 | 30 | 6 | 24711643 | |
| Pubmed | 3.08e-04 | 30 | 30 | 2 | 19401682 | ||
| Pubmed | 3.11e-04 | 153 | 30 | 3 | 10718198 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.13e-04 | 1105 | 30 | 6 | 35748872 | |
| Pubmed | 3.35e-04 | 157 | 30 | 3 | 30186101 | ||
| Pubmed | 3.69e-04 | 399 | 30 | 4 | 35987950 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 3.74e-04 | 163 | 30 | 3 | 22113938 | |
| Pubmed | 3.97e-04 | 34 | 30 | 2 | 12234937 | ||
| Pubmed | 3.98e-04 | 407 | 30 | 4 | 12693553 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 4.09e-04 | 410 | 30 | 4 | 26949251 | |
| Pubmed | 4.30e-04 | 754 | 30 | 5 | 35906200 | ||
| Pubmed | 4.40e-04 | 418 | 30 | 4 | 34709266 | ||
| Pubmed | 4.96e-04 | 38 | 30 | 2 | 28680062 | ||
| Pubmed | 4.96e-04 | 38 | 30 | 2 | 33283408 | ||
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 5.23e-04 | 39 | 30 | 2 | 19010793 | |
| Pubmed | 5.91e-04 | 809 | 30 | 5 | 32129710 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 6.35e-04 | 43 | 30 | 2 | 34672947 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 6.49e-04 | 197 | 30 | 3 | 22365833 | |
| Pubmed | 6.78e-04 | 469 | 30 | 4 | 27634302 | ||
| Cytoband | 15q15.1 | 4.38e-04 | 47 | 30 | 2 | 15q15.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 3.14e-03 | 127 | 30 | 2 | chr2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 4.18e-03 | 147 | 30 | 2 | chr15q15 | |
| Cytoband | 14q11.2 | 6.19e-03 | 180 | 30 | 2 | 14q11.2 | |
| GeneFamily | RNA binding motif containing | 1.39e-04 | 213 | 23 | 4 | 725 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-06 | 173 | 30 | 4 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-06 | 175 | 30 | 4 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-06 | 175 | 30 | 4 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.60e-06 | 175 | 30 | 4 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.73e-06 | 176 | 30 | 4 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.73e-06 | 176 | 30 | 4 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-06 | 177 | 30 | 4 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-06 | 178 | 30 | 4 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.12e-06 | 179 | 30 | 4 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.68e-06 | 183 | 30 | 4 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 7.75e-06 | 190 | 30 | 4 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.75e-06 | 190 | 30 | 4 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 196 | 30 | 4 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 196 | 30 | 4 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 196 | 30 | 4 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.94e-06 | 197 | 30 | 4 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.30e-06 | 199 | 30 | 4 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.49e-06 | 200 | 30 | 4 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 160 | 30 | 3 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 160 | 30 | 3 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.70e-04 | 161 | 30 | 3 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.76e-04 | 163 | 30 | 3 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.80e-04 | 164 | 30 | 3 | 9eed945e9b0c1ee5fc62724ac2bbbed4267b0678 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.80e-04 | 164 | 30 | 3 | f510f20e37e31b486cdd0e3f597ce4ff00877c5d | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.80e-04 | 164 | 30 | 3 | 5c932a462cbf81d029c8d11ec3aea3191529527b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-04 | 167 | 30 | 3 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.93e-04 | 168 | 30 | 3 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.93e-04 | 168 | 30 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.00e-04 | 170 | 30 | 3 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.00e-04 | 170 | 30 | 3 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.00e-04 | 170 | 30 | 3 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 171 | 30 | 3 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 171 | 30 | 3 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-04 | 173 | 30 | 3 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-04 | 173 | 30 | 3 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 174 | 30 | 3 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-04 | 177 | 30 | 3 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-04 | 177 | 30 | 3 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.25e-04 | 177 | 30 | 3 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 179 | 30 | 3 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 179 | 30 | 3 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-04 | 180 | 30 | 3 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.36e-04 | 180 | 30 | 3 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 181 | 30 | 3 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 182 | 30 | 3 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 182 | 30 | 3 | c6172aca2475bf0948a78e39f0dae6388504a915 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-04 | 183 | 30 | 3 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 2.48e-04 | 183 | 30 | 3 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.52e-04 | 184 | 30 | 3 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 184 | 30 | 3 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.56e-04 | 185 | 30 | 3 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 185 | 30 | 3 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 185 | 30 | 3 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-04 | 186 | 30 | 3 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-04 | 186 | 30 | 3 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | B_cell_maturation-immature_B_cell|B_cell_maturation / Lineage and Cell class | 2.64e-04 | 187 | 30 | 3 | 9afbb21654c8eb6f9c6a7cbd0664d890282ddceb | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.68e-04 | 188 | 30 | 3 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.68e-04 | 188 | 30 | 3 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.72e-04 | 189 | 30 | 3 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 189 | 30 | 3 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.77e-04 | 190 | 30 | 3 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 190 | 30 | 3 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.77e-04 | 190 | 30 | 3 | 4b9bac17eb7ceadada932f2d4a20a5f176088d53 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.81e-04 | 191 | 30 | 3 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 8597a8af294f24496c317d995f07eb5dcc25c13c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-04 | 192 | 30 | 3 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-04 | 192 | 30 | 3 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.85e-04 | 192 | 30 | 3 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 192 | 30 | 3 | 90274b85f3d612b6a6d435860cd6d049ddeb1d96 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-04 | 192 | 30 | 3 | 93903576dddd8227328e4ced75aa7625eedb9baf | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 192 | 30 | 3 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 193 | 30 | 3 | 45205ad1ef12aabf33059a7ff922a3bb86994c2f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 193 | 30 | 3 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 193 | 30 | 3 | 1beca3d3b34082b7d9112fbd094bee8019921ca0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 193 | 30 | 3 | 2ebb950476767f330241b0077ced22e55e124359 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-04 | 193 | 30 | 3 | cfab88935abe0a15632c5eec8ff00a857ec9b3ed | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 193 | 30 | 3 | d845beb0915a5b4bbd1e8f9b8d9322527a822849 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-04 | 194 | 30 | 3 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 194 | 30 | 3 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-04 | 194 | 30 | 3 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-04 | 194 | 30 | 3 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.99e-04 | 195 | 30 | 3 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.99e-04 | 195 | 30 | 3 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-04 | 195 | 30 | 3 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 195 | 30 | 3 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-04 | 195 | 30 | 3 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 2.99e-04 | 195 | 30 | 3 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 2.67e-08 | 7 | 28 | 3 | DOID:0050834 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.84e-05 | 69 | 28 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.99e-04 | 152 | 28 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | response to hydrochlorothiazide, fasting blood glucose measurement | 8.76e-04 | 46 | 28 | 2 | EFO_0004465, EFO_0005202 | |
| Disease | Neuroblastoma | 9.14e-04 | 47 | 28 | 2 | C0027819 | |
| Disease | QT interval | 1.54e-03 | 534 | 28 | 4 | EFO_0004682 | |
| Disease | pulmonary hypertension (is_marker_for) | 1.69e-03 | 64 | 28 | 2 | DOID:6432 (is_marker_for) | |
| Disease | serum IgE measurement | 1.69e-03 | 64 | 28 | 2 | EFO_0004579 | |
| Disease | word reading | 1.74e-03 | 65 | 28 | 2 | EFO_0005300 | |
| Disease | mucocutaneous lymph node syndrome | 2.37e-03 | 76 | 28 | 2 | EFO_0004246 | |
| Disease | Autism Spectrum Disorders | 2.95e-03 | 85 | 28 | 2 | C1510586 | |
| Disease | descending aortic diameter | 3.16e-03 | 88 | 28 | 2 | EFO_0021788 | |
| Disease | alpha fetoprotein measurement | 4.06e-03 | 100 | 28 | 2 | EFO_0010583 | |
| Disease | Seizures, Focal | 4.38e-03 | 104 | 28 | 2 | C0751495 | |
| Disease | S-6-hydroxywarfarin measurement | 5.00e-03 | 368 | 28 | 3 | EFO_0803326 | |
| Disease | bone fracture | 5.06e-03 | 112 | 28 | 2 | EFO_0003931 | |
| Disease | FEV/FEC ratio | 5.47e-03 | 1228 | 28 | 5 | EFO_0004713 | |
| Disease | bone density | 5.79e-03 | 388 | 28 | 3 | EFO_0003923 | |
| Disease | tea consumption measurement | 6.65e-03 | 129 | 28 | 2 | EFO_0010091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVEGVDFDKDCEDPE | 1681 | Q9HCK8 | |
| KDEDEDDNDDGCLKE | 116 | Q8TDI0 | |
| ALCEEEEDEDEGEAA | 141 | Q9NT62 | |
| DEEDVGKREFVEDGE | 211 | Q9BXY0 | |
| GEDDEEEEEEGFFQK | 31 | P0DMR3 | |
| LDCQGEEEEEEEDGS | 336 | Q8WYN3 | |
| EEEDDDDDKGDGFVE | 381 | Q8WYN3 | |
| EFEDDGSEKVLDEEG | 601 | O43719 | |
| EEEDEGSKFCEEDID | 1366 | Q3L8U1 | |
| CEEEEEVEEEKGSFC | 371 | P24394 | |
| DEEDEGSKFCEEDID | 966 | Q8TD26 | |
| CEEEEEEKKGDEDFT | 296 | Q9NRY5 | |
| EDVGDEGEEEKEFIS | 86 | Q14204 | |
| EEDDGEEEEDCIQVK | 591 | Q9UQL6 | |
| EEEEDCIQVKDEEGE | 596 | Q9UQL6 | |
| ELGFEEAEEDIKDIC | 81 | O95045 | |
| DDDLEGEVTEECGKF | 476 | Q9UHX1 | |
| HVCESKAEEEEGEGE | 421 | O95425 | |
| EGEGEGEEKEEDVCF | 431 | O95425 | |
| CEDEELEFKLVFGEE | 6 | Q14934 | |
| AVGCFEGDEEEEEDD | 736 | Q9ULV3 | |
| ADEEEEGDKEDTCEV | 421 | Q9UMS6 | |
| CKQDGEEGTEEDTEE | 926 | Q6ZNA4 | |
| DDKDGGIEVEESDEF | 81 | Q9P246 | |
| GEVDEDLEVETKEEC | 316 | Q96I25 | |
| QAGEDEEEECKEEAE | 401 | Q5TEJ8 | |
| DEEEKPDAEGKTECE | 31 | Q6IPX3 | |
| EELEDFDKDGDEDEC | 21 | Q96SB8 | |
| KEDEDEDEECPAGKA | 501 | Q9BWH6 | |
| DGKGEEEEEDYFDKE | 56 | Q9H2Y7 | |
| EEEEEEEDEGCKGLF | 481 | Q15911 | |
| DDGLCGEEEKVFEAL | 186 | Q2WGJ6 | |
| AGEDDDDDECGEEKL | 756 | P32418 |